| Term 
 
        | What is pulmoanry arterial hypertension (PAH)? |  | Definition 
 
        | continous high blood pressure in the pulmonary artery. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Walls of the pulmonary arteries can thicken as the amount of muscle increases in some arteries and scar tissue can form on the artery walls. As the walls thicken and scar, the arteries become increasingly narrow. Blood clots can form in the smaller arteries. These changes make it hard for the heart to push blood through the arteries and into the lungs. Thus, the pressure in the arteries rises. As a result of the heart working harder, the right ventricle becomes strained and weak and heart failure can result. Heart failure is the most common cause of death in people who have PAH.    |  | 
        |  | 
        
        | Term 
 
        | What is a defining characteristic of PAH? |  | Definition 
 
        | Reynaud's phenomenon   Reynaud's phenomenon: reduced blood supply causes discoloration and coldness in the fingers, toes, and occasionally other areas |  | 
        |  | 
        
        | Term 
 
        | How do prostacyclin drugs work? |  | Definition 
 
        | expand vessels in the lungs and allow blood to move through them with less resistance   |  | 
        |  | 
        
        | Term 
 
        | How do Endothelin receptor antagonists work? |  | Definition 
 
        | block endothelin, a vasoconstrictor |  | 
        |  | 
        
        | Term 
 
        | How do phosphodiesterase 5 - inhibitors work? |  | Definition 
 
        | relax the blood vessels in the lungs |  | 
        |  | 
        
        | Term 
 
        | Are calcium channel blockers ever used to treat PAH? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What other classes of drugs may be used (not for their vasodilation properities)? |  | Definition 
 
        | anticoagulants to reduce risk from blood clots and, occasionally, chemotherapeutics to reduce abnormal cell growth in the lung tissue |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Epoprostenol Treprostinil Liprost |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | Prostacyclin analogues drug interactions? |  | Definition 
 
        | may increase the effects of antihypertensives and antiplatelet agents |  | 
        |  | 
        
        | Term 
 
        | Name the endothelin receptor antagonists |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Are endothelin receptor antagonist indicated in pregnancy? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | Which of the endothelin antagonists has the most drug interactions? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | PDE5 inhibitors used in PAH? |  | Definition 
 
        | Sildenafil (Revatio) Tadalafil (Adcirca)   Note that the brand names are different! |  | 
        |  | 
        
        | Term 
 
        | Brand name for sildenafil indicated for PAH? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Statement. Not a question. |  | 
        |  | 
        
        | Term 
 
        | PDE5, indicated for PAH,  contraindication |  | Definition 
 
        | Do not give with PDE5 used for erectile dysfunction   &   Contraindicated with nitrates! |  | 
        |  | 
        
        | Term 
 
        | Should PDE5 inhibitors be given with alpha blockers? |  | Definition 
 
        | Caution with PDE5 inhibitors anc concurrent Alpha Blocker Therapy:   Tamsulosin (flomax) Doxazosin (Cardura)   |  | 
        |  |